AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1101611
Drug: Etidocaine 1%
RxNorm normalized name: etidocaine 1% preservative-free injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etidocaine 1% with adrenaline 5 mug/ml
Trial: 1101611
Drug: Bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.5% with adrenaline 5 mug/ml
Trial: 31062079
Drug: Tea catechin-enriched
RxNorm normalized name: catechin
DrugBank: Cianidanol (DB14086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tea catechin-enriched beverage (611 mg catechins, 88 mg caffeine)
Trial: 31062079
Drug: Placebo beverage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo beverage (0 mg catechins, 81 mg caffeine)
Trial: 29364091
Drug: Entecavir (ETV)
RxNorm normalized name: Entecavir
DrugBank: Entecavir (DB00442)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Entecavir (ETV) monotherapy
Trial: 30662324
Drug: LAM and
RxNorm normalized name: Alprazolam and propranolol only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAM and ADV combination therapy (Control)
Trial: 20570319
Drug: Nitrofurantoin (NFT)
RxNorm normalized name: Nitrofurantoin
DrugBank: Nitrofurantoin (DB00698)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nitrofurantoin (NFT) prophylaxis 100 mg b.i.d. for 7 days preoperatively
Trial: 20570319
Drug: Standard perioperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard perioperative antibiotic prophylaxis
Trial: 16476929
Drug: DCA (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DCA (25 mg/kg/day)
Trial: 9279344
Drug: TUT-7 (menogaril)
RxNorm normalized name: favor tutti frutti
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TUT-7 (menogaril) at 75 or 100 mg/body/day for 7 or 14 days with two-week drug withdrawal
Trial: 8443037
Drug: MDL 72394
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDL 72394 (MAO‐A inhibitor) 16 mg
Trial: 8443037
Drug: MDL 72974A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDL 72974A (MAO‐B inhibitor) 12 mg
Trial: 27793175
Drug: Luminor® paclitaxel‐coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Luminor® paclitaxel‐coated drug‐eluting balloon (DEB) catheter
Trial: 24322377
Drug: Gemcitabine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine plus S-1 (GS) combination chemotherapy
Trial: 22283861
Drug: T lymphocytes
RxNorm normalized name: Autologous Activated T Lymphocytes (ATL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T lymphocytes (CD3+) expression of glucocorticoid receptors (GCR) in late responders (LR)
Trial: 22283861
Drug: T lymphocytes
RxNorm normalized name: Autologous Activated T Lymphocytes (ATL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T lymphocytes (CD3+) expression of glucocorticoid receptors (GCR) in early responders (ER)
Trial: 22283861
Drug: T lymphocytes
RxNorm normalized name: Autologous Activated T Lymphocytes (ATL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T lymphocytes (CD3+) expression of glucocorticoid receptors (GCR)
Trial: 20334686
Drug: Behavioral weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral weight loss intervention (diet, physical activity, behavioral therapy)
Trial: 21910821
Drug: Enoxaparin (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (0.5 mg/kg body weight)
Trial: 18674465
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (5,000 units)
Trial: 12134175
Drug: 6 months
RxNorm normalized name: leuprolide 45 mg/6 months intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 months antiepileptic drug therapy
Trial: 12134175
Drug: 2 years
RxNorm normalized name: Childrens Panadol 5 - 12 Years
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 years antiepileptic drug therapy
Trial: 7995773
Drug: Inhaled recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled recombinant interferon gamma (r IFN-gamma) at doses of 0.1, 0.2, 0.6, 1.8, or 5.4 mg
Trial: 7995773
Drug: Inhaled recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled recombinant interferon gamma (r IFN-gamma)
Trial: 2186320
Drug: Doxorubicin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin (40 mg/m2) + Cyclophosphamide (600 mg/m2)
Trial: 2186320
Drug: Epirubicin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin (40 mg/m2) + Cyclophosphamide (600 mg/m2)
Trial: 2186320
Drug: Mitoxantrone (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitoxantrone (12 mg/m2) + Cyclophosphamide (600 mg/m2)
Trial: 2186320
Drug: Patients who
RxNorm normalized name: MAYZENT 0.25mg Tablet Starter Pack (For Patients Who Will Receive The 2mg Maintenance Dosage)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients who had previously received adjuvant chemotherapy
Trial: 406624
Drug: Marijuana low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marijuana low dose with aversive noise
Trial: 406624
Drug: Marijuana low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marijuana low dose without aversive noise
Trial: 406624
Drug: Marijuana high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marijuana high dose with aversive noise
Trial: 406624
Drug: Marijuana high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marijuana high dose without aversive noise
Trial: 28528567
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) consisting of 12 individual sessions with a psychologist over 16 weeks
Trial: 28528567
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment consisting of three consultations with an MS nurse over 16 weeks
Trial: 19757514
Drug: 2 l
RxNorm normalized name: H-2 locus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 l polyethylene glycol (group A)
Trial: 19757514
Drug: 4 l
RxNorm normalized name: PEG-4 laurate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 l polyethylene glycol (group B)
Trial: 20661545
Drug: Risedronate 5
RxNorm normalized name: risedronate 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 5 mg/day
Trial: 1653140
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg sumatriptan
Trial: 31872245
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g daily of icosapent ethyl
Trial: 31872245
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy (control)
Trial: 10574619
Drug: rHuIL-10 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuIL-10 at a dose of 4 or 8 microg/kg/day as a single daily subcutaneous injection for 28 days
Trial: 9064111
Drug: Orocal 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orocal 500 mg (one dissolve-in-the-mouth tablet in the morning and one in the evening)
Trial: 9064111
Drug: Cacit 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cacit 1000 (one effervescent tablet)
Trial: 9064111
Drug: Orocal 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orocal 500 mg (two tablets in a single dose)
Trial: 9064111
Drug: Orocal 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orocal 500 mg (two doses)
Trial: 6847466
Drug: Mild silver
RxNorm normalized name: mild silver protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mild silver protein solution (Argyrol)
Trial: 26347970
Drug: 4-hour transcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-hour transcutaneous tibial nerve stimulation for 6 weeks (total of 12 treatments)
Trial: 24247188
Drug: Pycnogenol 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pycnogenol 100 mg/day
Trial: 24247188
Drug: Pycnogenol 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pycnogenol 150 mg/day
Trial: 26088659
Drug: No pharmacotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No pharmacotherapy
Trial: 21661618
Drug: With pharmacotherapy
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: With pharmacotherapy
Trial: 19704167
Drug: Untreated (treatment-naive)
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Untreated (treatment-naive) group
Trial: 14572305
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g of intravenous magnesium sulphate (treatment trial)
Trial: 11262213
Drug: hPIV3 maternal
RxNorm normalized name: undecylenate
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: hPIV3 maternal antibody
Trial: 9151912
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with epirubicin (40 mg/m2 intra-arterial at 1 month after resection, followed by intravenous administration of 40 mg/m2 every 3 months for 2 years) and carmofur (300 mg/d orally for 24 months)
Trial: 28789663
Drug: Sodium nitrate
RxNorm normalized name: Sodium Nitrate
DrugBank: Sodium nitrate (DB15952)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium nitrate treatment
Trial: 26536702
Drug: Golden voice
RxNorm normalized name: GOLDEN SEAL
DrugBank: Goldenseal (DB16594)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Golden voice capsule
Trial: 26536702
Drug: Golden voice
RxNorm normalized name: GOLDEN SEAL
DrugBank: Goldenseal (DB16594)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Golden voice capsule and omeprazole
Trial: 24011069
Drug: LY2405319 (3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY2405319 (3, 10, or 20 mg daily for 28 days)
Trial: 12167446
Drug: Droperidol (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol (1.25 mg)
Trial: 10769552
Drug: 20 ppm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ppm inhaled nitric oxide
Trial: 8885949
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy without inhaled nitric oxide
Trial: 1570886
Drug: 4 ml
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 ml 0.5% bupivacaine/median approach
Trial: 1570886
Drug: 4 ml
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 ml 0.5% bupivacaine/paramedian approach
Trial: 26844723
Drug: Normal-dose therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal-dose therapy (2 μg exenatide, 0.2 U·kg·d BIA30, and 0.05 g MET twice daily)
Trial: 26844723
Drug: Low-dose therapy
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose therapy (0.5 μg exenatide, 0.05 U·kg·d BIA30, and 0.01 g MET twice daily)
Trial: 26844723
Drug: Normal-dose therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal-dose therapy
Trial: 26844723
Drug: Low-dose therapy
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose therapy
Trial: 26844723
Drug: Low-dose and
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose and normal-dose groups
Trial: 24649831
Drug: 6 weekly
RxNorm normalized name: tobramycin 28 MG inhalation powder 56 Weekly Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 weekly educational sessions promoting healthful nutrition and physical activity
Trial: 20613476
Drug: Cosyntropin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cosyntropin (1 mg intravenously)
Trial: 17625622
Drug: Adper Prompt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adper Prompt L-Pop with Z2000 (3M Espe)
Trial: 15702438
Drug: Regular pulsatile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular pulsatile insulin release pattern
Trial: 15702438
Drug: Irregular pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irregular pulse frequency insulin release pattern
Trial: 15702438
Drug: Irregular pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irregular pulse amplitude insulin release pattern
Trial: 15702438
Drug: Very fast-pulsatile
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very fast-pulsatile insulin release pattern
Trial: 15702438
Drug: Constant insulin
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constant insulin infusion
Trial: 12083474
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered lorazepam before surgery
Trial: 778989
Drug: Enteric-coated aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated aspirin (4.55 g daily)
Trial: 778989
Drug: Micro-encapsulated aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micro-encapsulated aspirin (4.50 g daily)
Trial: 778989
Drug: Micro-encapsulated aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micro-encapsulated aspirin
Trial: 778989
Drug: Both aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Both aspirin preparations
Trial: 24657236
Drug: Omalizumab 600
RxNorm normalized name: Omalizumab
DrugBank: Omalizumab (DB00043)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Omalizumab 600 mg
Trial: 23432142
Drug: Omalizumab 75
RxNorm normalized name: OMALIZUMAB 75MG/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omalizumab 75 mg
Trial: 19668245
Drug: Mood-stabilizing drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mood-stabilizing drug or neuroleptic in severe cases
Trial: 19668245
Drug: Lithium or
RxNorm normalized name: Lithium Orotate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium or anticonvulsant for prophylaxis
Trial: 9507989
Drug: Low DHA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low DHA (0.75 g/day)
Trial: 9507989
Drug: High DHA
RxNorm normalized name: Fish Oil/Stevia Extract 850 MG-10 MG Oral Packet [COROMEGA CHILD BRAIN & BODY HIGH DHA OMEGA-3]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High DHA (1.50 g/day)
Trial: 12365829
Drug: Ancrod treatment
RxNorm normalized name: ancrod
DrugBank: Ancrod (DB05099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ancrod treatment
Trial: 30257549
Drug: Alirocumab (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alirocumab (75 mg every 2 weeks, increased to 150 mg if LDL-C ≥ 70 mg/dL at week 8)
Trial: 31802485
Drug: Erythromycin infusion
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin infusion
Trial: 17726361
Drug: Multidimensional training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidimensional training program including moderate resistance exercise and balance exercise twice weekly for 6 months
Trial: 11808868
Drug: Thiocolchicoside, 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiocolchicoside, 4 mg ampoules (test formulation)
Trial: 11808868
Drug: Muscoril, 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Muscoril, 4 mg ampoules (reference formulation)
Trial: 23349486
Drug: Pioglitazone treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone treatment for 10 days
Trial: 23349486
Drug: Pioglitazone treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone treatment for 21 days
Trial: 19928571
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid and emoxypine during the first 10 days of standard chemotherapy
Trial: 16987112
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) withdrawal for 3 months
Trial: 8439024
Drug: 25 micrograms/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 micrograms/kg intravenous alfentanil
Trial: 8439024
Drug: 50 micrograms/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 micrograms/kg intravenous alfentanil
Trial: 3730521
Drug: Intravenous bromopride
RxNorm normalized name: bromopride
DrugBank: Bromopride (DB09018)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bromopride 10 mg
Trial: 3730521
Drug: Oral bromopride
RxNorm normalized name: bromopride
DrugBank: Bromopride (DB09018)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bromopride 20 mg
Trial: 3730521
Drug: Intramuscular bromopride
RxNorm normalized name: bromopride
DrugBank: Bromopride (DB09018)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular bromopride 20 mg
Trial: 3730521
Drug: Oral bromopride
RxNorm normalized name: bromopride
DrugBank: Bromopride (DB09018)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bromopride 10 mg
Trial: 3730521
Drug: Oral bromopride
RxNorm normalized name: bromopride
DrugBank: Bromopride (DB09018)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bromopride 30 mg
Trial: 30221595
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of enteric-coated aspirin
Trial: 20091934
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of epidural local anesthetics plus intravenous opioids
Trial: 20091934
Drug: Intravenous opioids
RxNorm normalized name: OPIOIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous opioids only
Trial: 16157797
Drug: 2% dorzolamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% dorzolamide 3 times daily
Trial: 16157797
Drug: 0.25% timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25% timolol maleate gel-forming solution once daily plus placebo twice daily (control)
Trial: 7570396
Drug: Therapeutic treatment
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic treatment
Trial: 444661
Drug: BCMP (melphalan,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCMP (melphalan, cyclophosphamide, and carmustine) with tapering course of prednisone
Trial: 444661
Drug: MP (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MP (oral melphalan) with tapering course of prednisone
Trial: 30557108
Drug: Focused extracorporeal
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Focused extracorporeal shockwave therapy (ESWT) with standard care
Trial: 30557108
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment with standard care
Trial: 25339110
Drug: Second-generation drug-eluting
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-generation drug-eluting stents (Resolute zotarolimus-eluting or Xience V everolimus-eluting stents)
Trial: 17679749
Drug: Gabapentin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (400 mg) administered twice weekly after HD sessions for four weeks
Trial: 17679749
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered twice weekly after HD sessions for four weeks
Trial: 11514042
Drug: Inhaled glucocorticosteroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled glucocorticosteroid (Pulmicort Turbuhaler)
Trial: 7621843
Drug: Bambuterol 20
RxNorm normalized name: bambuterol 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bambuterol 20 mg nocte
Trial: 3125773
Drug: Intermittent rectal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent rectal diazepam
Trial: 3125773
Drug: Continuous oral
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous oral sodium valproate
Trial: 29525281
Drug: LetiFend® vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LetiFend® vaccine
Trial: 27397444
Drug: Oral Vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Vitamin C (500 mg) twice daily for 7 days prior to surgery
Trial: 27397444
Drug: Antacid tablet
RxNorm normalized name: Calcium Carbonate 500 MG Oral Tablet, Chewable [GOOD SENSE ANTACID TABLETS]
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antacid tablet as placebo twice daily for 7 days prior to surgery
Trial: 27397444
Drug: Antacid tablet
RxNorm normalized name: Calcium Carbonate 500 MG Oral Tablet, Chewable [GOOD SENSE ANTACID TABLETS]
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antacid tablet as placebo
Trial: 27397444
Drug: Oral Vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Vitamin C (500 mg)
Trial: 20117571
Drug: Micro intervention
RxNorm normalized name: Lipantil Micro
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micro intervention (monthly home visits by a promotora over a 7-month period plus monthly mailed newsletters)
Trial: 12462550
Drug: Estrogen replacement
RxNorm normalized name: Norethindrone Acetate 1mg, Ethinyl Estradiol 5mcg Oral tablet [Estrogen Replacement/Osteoporosis]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen replacement therapy (ERT)